All terms in MESH
| Label | Id | Description |
|---|---|---|
| Corneal Transplantation | D016039 | [Partial or total replacement of the CORNEA from one human or animal to another.] |
| Refractive Surgical Procedures | D054140 | [Surgical procedures employed to correct REFRACTIVE ERRORS such as MYOPIA; HYPEROPIA; or ASTIGMATISM. These may involve altering the curvature of the CORNEA; removal or replacement of the CRYSTALLINE LENS; or modification of the SCLERA to change the axial length of the eye.] |
| HEATR2 protein, human | C578870 | |
| Neuropathy, Hereditary Sensory And Autonomic, Type I, With Cough And Gastroesophageal Reflux | C564296 | |
| Bile and Pancreatic Ducts, Complete Absence of | C564298 | |
| Diabetes Mellitus, Noninsulin-Dependent, Type 4 | C564299 | |
| Slc12a2 protein, rat | C578879 | |
| Gray Platelet Syndrome | D055652 | [A rare, inherited platelet disorder characterized by a selective deficiency in the number and contents of platelet alpha-granules. It is associated with THROMBOCYTOPENIA, enlarged platelets, and prolonged bleeding time.] |
| Blood Platelet Disorders | D001791 | [Disorders caused by abnormalities in platelet count or function.] |
| Blood Coagulation Disorders, Inherited | D025861 | [Hemorrhagic and thrombotic disorders that occur as a consequence of inherited abnormalities in blood coagulation.] |
| Muir-Torre Syndrome | D055653 | [A form of LYNCH SYNDROME II associated with cutaneous SEBACEOUS GLAND NEOPLASMS. Muir-Torre syndrome is also associated with other visceral malignant diseases include colorectal, endometrial, urological, and upper gastrointestinal neoplasms.] |
| Sebaceous Gland Neoplasms | D012626 | [New abnormal growth of tissue in the SEBACEOUS GLANDS.] |
| Skin Diseases, Genetic | D012873 | [Diseases of the skin with a genetic component, usually the result of various inborn errors of metabolism.] |
| Lynch Syndrome II | D055847 | [Hereditary nonpolyposis colorectal neoplasms associated with other malignancies, more commonly of ovarian or uterine origin. When also associated with SEBACEOUS GLAND NEOPLASMS, it is called MUIR-TORRE SYNDROME.] |
| NK Cell Lectin-Like Receptor Subfamily C | D055654 | [A subclass of NK cell lectin-like receptors that associates with members of NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D to form heterodimeric receptors for HLA-E antigen.] |
| Receptors, NK Cell Lectin-Like | D055630 | [Structurally-related receptors that are typically found on NATURAL KILLER CELLS. They are considered lectin-like proteins in that they share sequence homology with the carbohydrate binding domains of C-TYPE LECTINS. They differ from classical C-type lectins, however, in that they appear to lack CALCIUM-binding domains.] |
| Heterotopia, Periventricular, associated with Chromosome 5p Anomalies | C564291 | |
| NK Cell Lectin-Like Receptor Subfamily K | D055655 | [An activating NK cell lectin-like receptor subfamily that regulates immune responses to INFECTION and NEOPLASMS. Members of this subfamily generally occur as homodimers.] |
| Heterotopia, Periventricular, Autosomal Recessive | C564292 | |
| Pharmaceutical Services | D010593 | [Total pharmaceutical services provided by qualified PHARMACISTS. In addition to the preparation and distribution of medical products, they may include consultative services provided to agencies and institutions which do not have a qualified pharmacist., A pharmacy service model advocated by the pharmacy profession and approved by legislatures in many states and countries. This model expands the role of PHARMACISTS with additional training (CLINICAL PHARMACISTS) in a patient-centered evidence-based medication management program based on collaboration with physicians and patients.] |